Endothelial dysfunction predicted cardiovascular events in patients with paroxysmal atrial fibrillation

References

1. 1.↵
   1. Lau DH,
   2. Linz D,
   3. Sanders P.

   New findings in atrial fibrillation mechanisms. Card Electrophysiol Clin 2019; 11: 563–571.

   OpenUrl
2. 2.↵
   1. Xu S,
   2. Ilyas I,
   3. Little PJ,
   4. Li H,
   5. Kamato D,
   6. Zheng X, et al.

   Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev 2021; 73: 924–967.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Poredos P,
   2. Poredos AV,
   3. Gregoric I.

   Endothelial dysfunction and its clinical implications. Angiology 2021; 72: 604–615.

   OpenUrl
4. 4.↵
   1. Tan Q,
   2. Zhang S,
   3. Qi X,
   4. Zou X,
   5. Sun Q.

   Permanent atrial fibrillation impairs the function of circulating endothelial progenitor cells. Postgrad Med 2017; 129: 198–204.

   OpenUrl
5. 5.
   1. Komatsu T,
   2. Kunugita F,
   3. Ozawa M,
   4. Satoh Y,
   5. Yoshizawa R,
   6. Owada S, et al.

   Relationship between impairment of the vascular endothelial function and the CHA2DS2-VASc score in patients with sinus rhythm and non-valvular atrial fibrillation. Intern Med 2018; 57: 2131–2139.

   OpenUrl
6. 6.↵
   1. Corban MT,
   2. Toya T,
   3. Ahmad A,
   4. Lerman LO,
   5. Lee HC,
   6. Lerman A.

   Atrial fibrillation and endothelial dysfunction: a potential link? Mayo Clin Proc 2021; 96: 1609–1621.

   OpenUrl
7. 7.↵
   1. Haptonstall KP,
   2. Choroomi Y,
   3. Moheimani R,
   4. Nguyen K,
   5. Tran E,
   6. Lakhani K, et al.

   Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people. Am J Physiol Heart Circ Physiol 2020; 319: H547–H556.

   OpenUrlPubMed
8. 8.↵
   1. Thijssen DHJ,
   2. Bruno RM,
   3. van Mil ACCM,
   4. Holder SM,
   5. Faita F,
   6. Greyling A, et al.

   Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J 2019; 40: 2534–2547.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Alexander Y,
   2. Osto E,
   3. Schmidt-Trucksäss A,
   4. Shechter M,
   5. Trifunovic D,
   6. Duncker DJ, et al.

   Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc Res 2021; 117: 29–42.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Tan Q,
    2. Zhang S,
    3. Zou X,
    4. Zhao J,
    5. Hao J,
    6. Sun Q.

    Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients. Anatol J Cardiol 2017; 18: 103–107.

    OpenUrl
11. 11.↵
    1. Waechter C,
    2. Ausbuettel F,
    3. Chatzis G,
    4. Fischer D,
    5. Nef H,
    6. Barth S, et al.

    Analysis of atrial fibrillation treatment regimes in a multicenter cohort of transcatheter edge-to-edge mitral valve repair patients. J Interv Cardiol 2020; 2020: 6542028.

    OpenUrl
12. 12.↵
    1. Li Y,
    2. Tan Q,
    3. Guo Y,
    4. Wang Q,
    5. Ding L,
    6. Li H, et al.

    The influence of exercise training on endothelial function, serum irisin and inflammatory markers in the elderly with metabolic syndrome. Clin Lab 2021; 67.
13. 13.↵
    1. Premer C,
    2. Kanelidis AJ,
    3. Hare JM,
    4. Schulman IH.

    Rethinking endothelial dysfunction as a crucial target in fighting heart failure. Mayo Clin Proc Innov Qual Outcomes 2019; 3: 1–13.

    OpenUrl
14. 14.↵
    1. Maruhashi T,
    2. Soga J,
    3. Fujimura N,
    4. Idei N,
    5. Mikami S,
    6. Iwamoto Y, et al.

    Endothelial dysfunction, increased arterial stiffness, and cardiovascular risk prediction in patients with coronary artery disease: FMD-J (Flow-Mediated Dilation Japan) Study A. J Am Heart Assoc 2018; 7: e008588.

    OpenUrl
15. 15.↵
    1. Yuan C,
    2. Hou HT,
    3. Chen HX,
    4. Wang J,
    5. Wang ZQ,
    6. Chen TN, et al.

    Hydrogen sulfide-mediated endothelial function and the interaction with eNOS and PDE5A activity in human internal mammary arteries. J Int Med Res 2019; 47: 3778–3791.

    OpenUrl
16. 16.↵
    1. Tan Q,
    2. Li Y,
    3. Li X,
    4. Zhang S.

    Hyperinsulinemia impairs functions of circulating endothelial progenitor cells. Acta Diabetol 2019; 56: 785–795.

    OpenUrl
17. 17.↵
    1. Bai B,
    2. Yang Y,
    3. Wang Q,
    4. Li M,
    5. Tian C,
    6. Liu Y, et al.

    NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis 2020; 11: 776.

    OpenUrl